RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Omonike Olaleye to Drug Discovery

Back to Details
This is a "connection" page, showing publications Omonike Olaleye has written about Drug Discovery.
Omonike Olaleye
Connection Strength
0.436
Drug Discovery
  1. Olaleye OA, Bishai WR, Liu JO. Targeting the role of N-terminal methionine processing enzymes in Mycobacterium tuberculosis. Tuberculosis (Edinb). 2009 Dec; 89 Suppl 1:S55-9.
    View in: PubMed
    Score: 0.328
  2. Vijayakumar S, Finney John S, Nusbaum RJ, Ferguson MR, Cirillo JD, Olaleye O, Endsley JJ. In vitro model of mycobacteria and HIV-1 co-infection for drug discovery. Tuberculosis (Edinb). 2013 Dec; 93 Suppl:S66-70.
    View in: PubMed
    Score: 0.108
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support